Researchers at Ohio State University received a $4.3 million Cancer Center Support Grant from the NIH this year. Led by Dr. Michael Caligiuri, the Ohio State Comprehensive Cancer Center is one of only 41 designated comprehensive cancer centers in the nation. According to the Ohio State University website, the Arthur G. James Cancer Hospital and Richard J. Solove Research Institute are focused on creating a better understanding of laboratory, clinical and population-based cancer research. Researchers at Ohio State University make it their goal to develop more effective approaches to cancer prevention, diagnosis and therapies.
The NIH RePORTER describes the Ohio State University Comprehensive Cancer Center in further detail in the project’s abstract:
“The Ohio State University Comprehensive Cancer Center (OSUCCC) is currently in its 35th year as an NCI designated CCC and is now requesting continued federal support for the next five years. Dr. Caligiuri currently continues in his seventh year as the OSUCCC Director and has since been named CEO of OSU's freestanding James Cancer Hospital. The overall goal remains to reduce cancer morbidity and mortality through continued basic, translational and clinical research. The 239 OSUCCC full, associate or introductory members are currently served by 18 shared resources and are distributed among the our six Research Programs which remain unchanged: Cancer Control, Experimental Therapeutics, Innate Immunity, Molecular Biology and Cancer Genetics, Molecular Carcinogenesis and Chemoprevention, and Viral Oncology.”
Columbus BioResearch Product Faire™ Event 2011
In addition to receiving $4.3 million for cancer research from the NIH, Ohio State University also received $44.2 million in NSF funding in 2012. $6.9 million of that funding was given to life science research projects alone. The NSF funding was distributed among projects in a number of life science disciplines, including physiology and structural systems, plant genome research, molecular biophysics, neural systems, cellular dynamics and function, genetic mechanisms, systematics and biodiversity science, systems and synthetic biology, and living stock collections. Ohio State University also received $142.2 million from the NIH in 2012. For a full list of departments receiving NIH funding organized by department name, number of awards received and total funding awarded, please visit the NIH website.
Given the wealth of NSF and NIH research funding available at Ohio State University, lab suppliers interested in marketing life science solutions and lab products at Ohio life science marketing events want to take a closer look at Biotechnology Calendar, Inc.’s Columbus BioResearch Product Faire™ Event. Last year, the Columbus BioResearch Product Faire™ Event attracted 280 attendees, of which 186 were purchasing agents, professors and post docs, and 31 were lab managers. The attendees came from 35 different research buildings and 55 departments around campus.
Biotechnology Calendar, Inc. is a full-service science research marketing and events-planning company that has been organizing life science marketing events at top research institutions across the country for 20 years. If you’re interested marketing your life science solutions and lab products at life science marketing events closer to home, we encourage you to view our 2013 calendar of events. For more information on our Columbus BioResearch Product Faire™ Event, or to view more funding statistics for Ohio State University, click on the button below.
